David Dykeman, who co-chairs the Global Life Sciences & Medical Technology Group at international law firm the Greenberg Traurig, is a registered patent attorney with over 25 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in medical devices, robotics, materials, life sciences, and healthcare information technology. David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities.